Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci Res ; 91(3): 363-73, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23280518

ABSTRACT

Cuprizone intoxication is one of several animal models used to study demyelination and remyelination. Early treatment protocols exposed mice to cuprizone for 6 weeks to induce demyelination; however, more recent reports have varied exposure times from 4 to 5 weeks. The goal of this study was to determine the minimal exposure of cuprizone in C57BL/6 mice that would induce a pathology of robust demyelination and gliosis similar to that described for a 5- or 6-week treatment. We found that an abbreviated insult of only 2 weeks of exposure to cuprizone induced significant demyelination 3 weeks later (5-week time point) but was somewhat variable. Three weeks of exposure to cuprizone produced extensive demyelination by week 5, equivalent to that observed with 5 weeks of exposure. The depletion of mature oligodendrocytes, as well as microglia and astrocyte accumulation, showed trends similar to those with 5-week exposure to cuprizone. Once mature oligodendrocytes are perturbed after a 3-week treatment, the progression to demyelination occurs without requiring further exposure. Furthermore, the early removal of cuprizone did not accelerate remyelination, suggesting that other sequences of events must follow before repair can occur. Thus, a short, "hit and run" CNS insult triggers a cascade of events leading to demyelination 2-3 weeks later.


Subject(s)
Cuprizone/toxicity , Demyelinating Diseases/chemically induced , Demyelinating Diseases/pathology , Oligodendroglia/drug effects , Oligodendroglia/pathology , Animals , Cell Count/methods , Cell Death/drug effects , Cuprizone/administration & dosage , Male , Mice , Mice, Inbred C57BL , Time Factors
2.
J Immunol ; 188(10): 4906-12, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22490868

ABSTRACT

Chronic inflammatory demyelinating polyneuropathy is a debilitating autoimmune disease characterized by peripheral nerve demyelination and dysfunction. How the autoimmune response is initiated, identity of provoking Ags, and pathogenic effector mechanisms are not well defined. The autoimmune regulator (Aire) plays a critical role in central tolerance by promoting thymic expression of self-Ags and deletion of self-reactive T cells. In this study, we used mice with hypomorphic Aire function and two patients with Aire mutations to define how Aire deficiency results in spontaneous autoimmune peripheral neuropathy. Autoimmunity against peripheral nerves in both mice and humans targets myelin protein zero, an Ag for which expression is Aire-regulated in the thymus. Consistent with a defect in thymic tolerance, CD4(+) T cells are sufficient to transfer disease in mice and produce IFN-γ in infiltrated peripheral nerves. Our findings suggest that defective Aire-mediated central tolerance to myelin protein zero initiates an autoimmune Th1 effector response toward peripheral nerves.


Subject(s)
Immune Tolerance , Myelin P0 Protein/deficiency , Point Mutation , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/immunology , Transcription Factors/deficiency , Transcription Factors/genetics , Amino Acid Sequence , Animals , Autoantibodies/blood , Disease Models, Animal , Female , Humans , Immune Tolerance/genetics , Mice , Mice, Inbred NOD , Mice, Mutant Strains , Mice, SCID , Molecular Sequence Data , Myelin P0 Protein/genetics , Myelin P0 Protein/physiology , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/blood , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/genetics , Transcription Factors/physiology , AIRE Protein
3.
Neurobiol Dis ; 39(2): 127-37, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20347981

ABSTRACT

In addition to regulating reproductive functions in the brain and periphery, estrogen has tropic and neuroprotective functions in the central nervous system (CNS). Estrogen administration has been demonstrated to provide protection in several animal models of CNS disorders, including stroke, brain injury, epilepsy, Parkinson's disease, Alzheimer's disease, age-related cognitive decline and multiple sclerosis. Here, we use a model of toxin-induced oligodendrocyte death which results in demyelination, reactive gliosis, recruitment of oligodendrocyte precursor cells and subsequent remyelination to study the potential benefit of 17beta-estradiol (E2) administration in male mice. The results indicate that E2 partially ameliorates loss of oligodendrocytes and demyelination in the corpus callosum. This protection is accompanied by a delay in microglia accumulation as well as reduced mRNA expression of the pro-inflammatory cytokine, tumor necrosis factor alpha (TNFalpha), and insulin-like growth factor-1 (IGF-1). E2 did not significantly alter the accumulation of astrocytes or oligodendrocyte precursor cells, or remyelination. These data obtained from a toxin-induced, T cell-independent model using male mice provide an expanded view of the beneficial effects of estrogen on oligodendrocyte and myelin preservation.


Subject(s)
Cuprizone/toxicity , Demyelinating Diseases , Estradiol/therapeutic use , Estrogens/therapeutic use , Monoamine Oxidase Inhibitors/toxicity , Oligodendroglia/drug effects , Animals , Antigens/metabolism , Cell Count/methods , Demyelinating Diseases/chemically induced , Demyelinating Diseases/pathology , Demyelinating Diseases/prevention & control , Disease Models, Animal , Drug Interactions , Estradiol/blood , Gene Expression Regulation/drug effects , Glial Fibrillary Acidic Protein/metabolism , Glutathione Transferase/metabolism , Indoles , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Macrophages/drug effects , Male , Mice , Mice, Inbred C57BL , Microglia/drug effects , Microglia/physiology , Periodic Acid , Plant Lectins , Proteoglycans/metabolism , Stem Cells/drug effects , Stem Cells/physiology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
4.
J Neurosci Res ; 88(2): 391-402, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-19746424

ABSTRACT

Multiple sclerosis is a demyelinating neurological disease that is influenced by gender, primarily reflected in greater susceptibility to disease development in women than in men. Cuprizone intoxication, an animal model that is used to study demyelination and remyelination, has been extensively characterized in male C57BL/6 mice. Here, we have undertaken a comprehensive characterization of the morphological and cellular processes that occur in female C57BL/6J mice during cuprizone-induced demyelination and subsequent remyelination and compared them with age-matched male mice. We find that the pattern of demyelination and remyelination is similar between genders and that there is little or no difference in the loss or repopulation of mature oligodendrocytes or accumulation of reactive glia. Furthermore, examination of alphaERKO and betaERKO mice suggests that estrogen receptors do not affect the outcome for demyelination or remyelination. Interestingly, we found that cuprizone treatment disrupts estrous cyclicity in female mice, possibly interfering with potential hormone influences on demyelination and remyelination. Therefore, cuprizone-induced demyelination in C57BL/6J mice may have limitations as a model for the study of sex differences.


Subject(s)
Chelating Agents/toxicity , Cuprizone/toxicity , Demyelinating Diseases/chemically induced , Demyelinating Diseases/physiopathology , Estrous Cycle/drug effects , Sex Characteristics , Animals , Cell Death/drug effects , Cell Death/physiology , Corpus Callosum/drug effects , Corpus Callosum/pathology , Corpus Callosum/physiopathology , Demyelinating Diseases/pathology , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/genetics , Estrogen Receptor beta/metabolism , Female , Genitalia/drug effects , Genitalia/pathology , Genitalia/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Microglia/drug effects , Microglia/pathology , Microglia/physiology , Nerve Regeneration/drug effects , Oligodendroglia/drug effects , Oligodendroglia/pathology , Oligodendroglia/physiology , Organ Size/drug effects , Organ Size/physiology
5.
Brain Pathol ; 19(3): 467-79, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19016742

ABSTRACT

The role of mouse strain and the influence of gender on demyelination were explored for the first time in SJL mice using the cuprizone intoxication model. We document here that SJL mice display a unique pattern of demyelination that did not follow the profile that is well-characterized in C57BL/6 mice. The SJL mice did not readily demyelinate at the midline within the corpus callosum but showed greater demyelination immediately lateral to midline. During continuous exposure to cuprizone, demyelination was not complete and appeared to plateau after week 7. Importantly, female mice were partially resistant to demyelination, whereas male mice were more severely demyelinated. Differences in the number of mature oligodendrocytes were consistent with the extent of demyelination; however, microglia, astrocyte and oligodendrocyte precursor cell populations did not differ between male and female mice. Thus, genetic factors and gender influence susceptibility to demyelinating disease in the cuprizone model, which may provide additional insights into the variability observed in human demyelinating diseases such as multiple sclerosis.


Subject(s)
Brain/pathology , Chelating Agents/toxicity , Cuprizone/toxicity , Demyelinating Diseases/pathology , Animals , Astrocytes/cytology , Cell Count , Demyelinating Diseases/chemically induced , Demyelinating Diseases/genetics , Disease Models, Animal , Female , Immunohistochemistry , Male , Mice , Microglia/cytology , Multiple Sclerosis/genetics , Multiple Sclerosis/pathology , Oligodendroglia/cytology , Sex Characteristics , Stem Cells/cytology
6.
Gene ; 358: 1-16, 2005 Sep 26.
Article in English | MEDLINE | ID: mdl-16040208

ABSTRACT

One of the most important processes to the survival of a species is its ability to reproduce. In plants, SEPALLATA-class MADS-box genes have been found to control the development of the inner whorls of flowers. However, while much is known about floral development in herbaceous plants, similar systems in woody trees remain poorly understood. Populus tremuloides (trembling aspen) is a widespread North American tree having important economic value, and its floral development differs from that of well-studied species in that the flowers have only two whorls and are truly unisexual. Sequence based analyses indicate that PTM3 (Populus tremuloides MADS-box 3), and a duplicate gene PTM4, are related to the SEPALLATA1-and 2-class of MADS-box genes. Another gene, PTM6, is related to SEP3, and each of these genes has a counterpart in the poplar genomic database along with additional members of the A, B, C, D, and E-classes of MADS-box genes. PTM3/4 and 6 are expressed in all stages of male and female aspen floral development. However, PTM3/4 is also expressed in the terminal buds, young leaves, and young stems. In situ RNA localization identified PTM3/4 and 6 transcripts predominantly in the inner, sexual whorl, within developing ovules of female flowers and anther primordia of male flowers. Tree researchers often use heterologous systems to help study tree floral development due to the long juvenile periods found in most trees. We found that the participation of PTM3/4 in floral development is supported by transgenic experiments in both P. tremuloides and heterologous systems such as tobacco and Arabidopsis. However, phenotypic artifacts were observed in the heterologous systems. Together the results suggest a role for poplar SEP-class genes in reproductive viability.


Subject(s)
Flowers/genetics , Gene Expression Regulation, Plant/physiology , Genes, Plant/physiology , Plant Proteins/genetics , Populus/genetics , Transcription Factors/genetics , Arabidopsis/genetics , Arabidopsis/metabolism , Flowers/metabolism , Gene Duplication , Plant Leaves/genetics , Plant Leaves/metabolism , Plant Proteins/metabolism , Populus/metabolism , Reproduction/genetics , Sex Determination Processes , Nicotiana/genetics , Nicotiana/metabolism , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...